Yoram Azulai
Chief Executive Officer presso HBL - HADASIT BIO-HOLDINGS LTD
Profilo
Yoram Azulai is currently the Chief Executive Officer, CFO & Secretary at HBL- Hadasit Bio-Holdings Ltd.
He is also a Director at Zingenix Ltd.
and Tolaren Ltd.
Previously, he served as a Director at ProtAb Ltd.
Posizioni attive di Yoram Azulai
| Società | Posizione | Inizio |
|---|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Chief Executive Officer | 31/03/2020 |
Zingenix Ltd.
 Zingenix Ltd. BiotechnologyHealth Technology Zingenix Ltd. provides gene therapy for orphan disorders. The private company is based in Tel Aviv, Israel. | Director/Board Member | - |
| Tolaren Ltd. | Director/Board Member | - |
Precedenti posizioni note di Yoram Azulai
| Società | Posizione | Fine |
|---|---|---|
ProtAb Ltd.
 ProtAb Ltd. Pharmaceuticals: MajorHealth Technology ProtAb Ltd. develops drug treatment for rheumatoid arthritis. It develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune inflammatory diseases. The company was Founded by Yaakov Naparstek in 2005 and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| Aziende private | 3 |
|---|---|
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology ProtAb Ltd. develops drug treatment for rheumatoid arthritis. It develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune inflammatory diseases. The company was Founded by Yaakov Naparstek in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Zingenix Ltd.
Zingenix Ltd. BiotechnologyHealth Technology Zingenix Ltd. provides gene therapy for orphan disorders. The private company is based in Tel Aviv, Israel. | Health Technology |
| Tolaren Ltd. |
- Borsa valori
- Insiders
- Yoram Azulai
